Hydration and Health Promotion: A Brief Introduction

Journal of the American College of Nutrition

Volumn 26, Issue , 2007, Pages 533S-534S

  Buyckx, Maxime E ^a  

^a University of Georgia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER;

BODY WATER; CARDIOVASCULAR SYSTEM; CELL METABOLISM; CHRONIC DISEASE; DEHYDRATION; DIETARY INTAKE; EDITORIAL; EXERCISE; FLUID INTAKE; GENETIC ANALYSIS; HEALTH PROGRAM; HEALTH PROMOTION; HOMEOSTASIS; HUMAN; HYDRATION; LIVER CLEARANCE; PHYSICAL CAPACITY; WELLBEING;

DRINKING; HEALTH PROMOTION; HUMANS;

EID: 34848857032     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2007.10719654     Document Type: Article

References (22)

1. cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 14: 281-289, 2000.
2. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ: Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta. Immunol Cell Biol 78: 74-79, 2000.
3. Fell JM: Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J Parenter Enteral Nutr 29(4 Suppl): S126-128, 2005.
4. Harsha WT, Kalandarova E, McNutt P, Irwin R, Noel J: Nutritional supplementation with transforming growth factor-beta, glutamine, and short chain fatty acids minimizes methotrexateinduced injury. J Pediatr Gastroenterol Nutr 42: 53-58, 2006.
5. Tsai WY, Chang WH, Chen CH, Lu FJ: Enchancing effect of patented whey protein isolate (Immunocal) on cytotoxicity of an anticancer drug. Nutr Cancer 38: 200-208, 2000.
6. Furlong SJ, Mader JS, Hoskin DW: Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncol Rep 15: 1385-1390, 2006.
7. Di Mario F, Aragona G, Bo ND, Ingegnoli A, Cavestro GM, Moussa AM, Iori V, Leandro G, Pilotto A, Franze A: Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol 36: 396-398, 2003.
8. Andersen JH, Jenssen H, Gutteberg TJ: Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res 58: 209-215, 2003.
9. Marshall K: Therapeutic applications of whey protein. Altern Med Rev 9: 136-156, 2004.
10. Ajello M, Greco R, Giansanti F, Massucci MT, Antonini G, Valenti P: Anti-invasive activity of bovine lactoferrin towards group A Streptococci. Biochem Cell Biol 80: 119-124, 2002.
11. Petitclerc D, Lauzon K, Cochu A, Ster C, Diarra MS, Lacasse P: Efficacy of a lactoferrin-penicillin combination to treat (beta)-lactam-resistant Staphylococcus aureus mastitis. J Dairy Sci 90: 2778-2787, 2007.
12. Chimura T, Hirayama T, Nakahara M: In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil. Jpn J Antibiot 46: 482-485, 1993.
13. Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD: The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res 15: 2643-2649, 1995.
14. Bounous G, Batist G, Gold P: Whey proteins in cancer prevention. Cancer Lett 57: 91-94, 1991.
15. Watanabe A, Okada K, Shimizu Y, Wakabayashi H, Higuchi K, Niiya K, Kuwabara Y, Yasuyama T, Ito H, Tsukishiro T, Kondoh Y, Emi N, Kohri H: Nutritional therapy of chronic hepatitis by whey protein (non-heated). J Med 31: 283-302, 2000.
16. Hayes TG, Falchook GF, Varadhachary GR, Smith DP, Davis LD, Dhingra HM, Hayes BP, Varadhachary A: Phase I trial of oral talactoferrin alfa in refractory solid tumors. Invest New Drugs 24: 233-240, 2006.
17. McBride D: Talactoferrin alpha receives fast-track designation for the treatment of non-small cell lung cancer. ONS Connect 22: 14, 2007.
18. Lyons TE, Miller MS, Serena T, Sheehan P, Lavery L, Kirsner RS, Armstrong DG, Reese A, Yankee EW, Veves A: Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg 193: 49-54, 2007.
19. Colker CM, Swain M, Lynch L, Gingerich DA: Effects of a milk-based bioactive micronutrient beverage on pain symptoms and activity of adults with osteoarthritis: a double-blind, placebocontrolled clinical evaluation. Nutrition 18: 388-392, 2002.
20. Pins JJ, Keenan JM: Effects of whey peptides on cardiovascular disease risk factors. J Clin Hypertens (Greenwich) 8: 775-782, 2006.
21. Zavaleta N, Figueroa D, Rivera J, Sanchez J, Alfaro S, Lonnerdal B: Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea. J Pediatr Gastroenterol Nutr 44: 258-264, 2007.
22. Chabance B, Marteau P, Rambaud JC, Migliore-Samour D, Boynard M, Perrotin P, Guillet R, Jolles P, Fiat AM: Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 80: 155-165, 1998.